Side-by-side financials for CODX and DXCM. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | CODX | DXCM |
|---|---|---|
| Market cap | - | $29.08 B |
| US-listed rank | - | #478 |
| Revenue (latest FY) | $622.49K | $4.66B |
| Net income (latest FY) | -$46.90M | $836.30M |
| Net margin | -7533.6% | 17.9% |
| P/E (trailing FY) | - | 34.8 |
| SEC filings | 355 | 2,566 |
In their latest fiscal years, Co-Diagnostics, Inc. reported $622.49K in revenue while DEXCOM INC reported $4.66B.
Full pages: Co-Diagnostics, Inc. and DEXCOM INC, or browse the full rankings.